Repare Therapeutics Inc (RPTX) concluded trading on Wednesday at a closing price of $1.53, with 6.94 million shares of worth about $10.62 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.79% during that period and on July 16, 2025 the price saw a gain of about 6.99%. Currently the company’s common shares owned by public are about 42.89M shares, out of which, 30.77M shares are available for trading.
Stock saw a price change of -3.16% in past 5 days and over the past one month there was a price change of 4.29%. Year-to-date (YTD), RPTX shares are showing a performance of -56.03% which increased to 16.79% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.89 but also hit the highest price of $4.29 during that period. The average intraday trading volume for Repare Therapeutics Inc shares is 262.99K. The stock is currently trading 5.34% above its 20-day simple moving average (SMA20), while that difference is up 8.02% for SMA50 and it goes to -17.43% lower than SMA200.
Repare Therapeutics Inc (NASDAQ: RPTX) currently have 42.89M outstanding shares and institutions hold larger chunk of about 42.30% of that.
The stock has a current market capitalization of $65.62M and its 3Y-monthly beta is at 0.92. It has posted earnings per share of -$3.01 in the same period. It has Quick Ratio of 7.42 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RPTX, volatility over the week remained 8.42% while standing at 4.79% over the month.
Analysts are in expectations that Repare Therapeutics Inc (RPTX) stock would likely to be making an EPS of -0.56 in the current quarter, while forecast for next quarter EPS is -0.49 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.56 which is -0.56 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.82 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -5.46% while it is estimated to increase by 26.55% in next year. EPS is likely to grow at an annualized rate of -5.53% for next 5-years, compared to annual growth of -21.89% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on June 09, 2023 offering a Buy rating for the stock and assigned a target price range of between $11 and $16 to it. Coverage by Morgan Stanley stated Repare Therapeutics Inc (RPTX) stock as an Equal-weight in their note to investors on February 03, 2023, suggesting a price target of $15 for the stock. On January 06, 2023, CapitalOne Initiated their recommendations, while on April 12, 2022, Stifel Downgrade their ratings for the stock with a price target of $11. Stock get a Buy rating from Goldman on March 17, 2022.
